US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

enVVeno Medical Corp.

3.11

+0.11003.67%

Volume:26.57K

Turnover:83.39K

Market Cap:54.54M

PE:-2.44

High:3.19

Open:3.04

Low:3.02

Close:3.00

Loading ...

Overview Company News Filings

enVVeno Medical reports Q1 EPS (22c) vs. (31c) last year

enVVeno Medical Says Ended Q1 2025 With $38.9M In Cash, Investments

enVVeno Medical Reports First Quarter 2025 Financial Results and Reiterates Progress Toward VenoValve FDA Decision Expected in 2H24

ACCESS Newswire

VenoValve to be Featured During Presentation at the 47th Annual Charing Cross Symposium

ACCESS Newswire

enVVeno Medical to Participate in a Live Virtual Investor Closing Bell Segment

ACCESS Newswire

The Impact of the VenoValve(R) on Patients with Primary and Secondary Chronic Venous Insufficiency (CVI) to be Presented at the Society for Clinical Vascular Surgery 52nd Annual Symposium

ACCESS Newswire

BRIEF-enVVeno Medical Files For Mixed Shelf Of Up To $100 Million - SEC Filing

enVVeno Medical files $100M mixed securities shelf

enVVeno Medical Corp reports results for the quarter ended December 31 - Earnings Summary

enVVeno Medical FY 2024 GAAP EPS $(1.27) Beats $(1.32) Estimate

enVVeno Medical Reports Fourth Quarter and Year-End 2024 Financial Results and Progress Towards VenoValve FDA Approval Expected in 2H25

ACCESS Newswire

enVVeno Medical Corp expected to post a loss of 35 cents a share - Earnings Preview

enVVeno Medical presents one-year data from VenoValve trial

One-Year Data from the VenoValve(R) U.S. Pivotal Trial Highlighting Impact on Patients' Quality of Life (QOL) to be Presented Today at the 37th Annual Meeting of the American Venous Forum

ACCESS Newswire

Interim Two-Year Follow-Up Data from the VenoValve(R) U.S. Pivotal Trial to be Presented Today at the VESS 2025 Annual Winter Meeting

ACCESS Newswire

Companies Like enVVeno Medical (NASDAQ:NVNO) Are In A Position To Invest In Growth

Simply Wall St.

enVVeno Medical completes final wave of implants in pre-clinical GLP study

enVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for enVVe

enVVeno launches recap website highlighting VEITH Symposium participation

enVVeno Medical Highlights Successful 2024 VEITH Symposium with Launch of Recap Website

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NVNO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVNO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVNO\",,,,,undefined,":{"symbol":"NVNO","market":"US","secType":"STK","nameCN":"enVVeno Medical Corp.","latestPrice":3.11,"timestamp":1746112064346,"preClose":3,"halted":0,"volume":26574,"delay":0,"floatShares":17374380,"shares":17535948,"eps":-1.272838,"marketStatus":"Trading","change":0.11,"latestTime":"05-01 11:12:31 EDT","open":3.0405,"high":3.19,"low":3.0211,"amount":83391.6196044,"amplitude":0.0563,"askPrice":3.17,"askSize":120,"bidPrice":3.12,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-1.272838,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746129600000},"marketStatusCode":2,"adr":0,"listingDate":1527739200000,"exchange":"NASDAQ","adjPreClose":3,"preHourTrading":{"tag":"盘前","latestPrice":3,"preClose":3,"latestTime":"08:31 EDT","volume":502,"amount":1503.7899952,"timestamp":1746102700789},"postHourTrading":{"tag":"盘后","latestPrice":3.19,"preClose":3,"latestTime":"18:32 EDT","volume":502,"amount":1601,"timestamp":1746052356815},"volumeRatio":2.53782,"impliedVol":0.5236,"impliedVolPercentile":0.072},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVNO\",,,,,undefined,":{"symbol":"NVNO","floatShares":17374380,"roa":"-31.82%","roe":"-49.39%","lyrEps":-1.272838,"volumeRatio":2.53782,"shares":17535948,"dividePrice":0,"high":3.19,"amplitude":0.0563,"preClose":3,"low":3.0211,"week52Low":2.0278,"pbRate":"1.29","week52High":6.48,"institutionHeld":0,"latestPrice":3.11,"committee":-0.411765,"eps":-1.272838,"divideRate":0,"volume":26574,"delay":0,"ttmEps":-1.272838,"open":3.0405,"prevYearClose":3.02,"prevWeekClose":2.735,"prevMonthClose":3,"prevQuarterClose":2.63,"fiveDayClose":2.73,"twentyDayClose":2.59,"sixtyDayClose":3.26},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVNO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532907263","title":"enVVeno Medical reports Q1 EPS (22c) vs. (31c) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2532907263","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532907263?lang=en_us&edition=fundamental","pubTime":"2025-05-01 20:41","pubTimestamp":1746103301,"startTime":"0","endTime":"0","summary":"Robert Berman, enVVeno Medical’s (NVNO) Chief Executive Officer, commented “In the first quarter, we continued to present our compelling 1-year dat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/envveno-medical-reports-q1-eps-22c-vs-31c-last-year?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/envveno-medical-reports-q1-eps-22c-vs-31c-last-year?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","NVNO"],"gpt_icon":0},{"id":"2532071568","title":"enVVeno Medical Says Ended Q1 2025 With $38.9M In Cash, Investments","url":"https://stock-news.laohu8.com/highlight/detail?id=2532071568","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532071568?lang=en_us&edition=fundamental","pubTime":"2025-05-01 20:09","pubTimestamp":1746101371,"startTime":"0","endTime":"0","summary":"enVVeno Medical Says Ended Q1 2025 With $38.9M In Cash, Investments","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45132768/envveno-medical-says-ended-q1-2025-with-38-9m-in-cash-investments","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVNO","BK4082"],"gpt_icon":0},{"id":"2532077870","title":"enVVeno Medical Reports First Quarter 2025 Financial Results and Reiterates Progress Toward VenoValve FDA Decision Expected in 2H24","url":"https://stock-news.laohu8.com/highlight/detail?id=2532077870","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532077870?lang=en_us&edition=fundamental","pubTime":"2025-05-01 20:05","pubTimestamp":1746101100,"startTime":"0","endTime":"0","summary":"Cash Burn of $4.0 million in Q1 remains in line with projected quarterly range. Cash and investments on hand are sufficient to fund operations beyond the anticipated FDA decision of VenoValve and the initiation of the enVVe pivotal trial. FDA decision on PMA application for the VenoValve expected in the second half of 2025. On track for enVVe IDE application submission in Q3 of 2025, pending GLP study results. Robert Berman, enVVeno Medical's Chief Executive Officer, commented \"In the first quarter, we continued to present our compelling 1-year data from the U.S. pivotal trial at leading global, scientific conferences to socialize and engage directly with leading vascular surgeons as we lay the foundation for the potential phased market entry of the VenoValve, pending FDA approval. We have also maintained a strong financial position - an important advantage in the current market conditions. We remain confident that 2025 will be a pivotal year as we prepare for our transition from a dev","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/envveno-medical-reports-first-quarter-120500690.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CVI","NVNO","LU2065732104.USD","IDE","PRGS","BK4082","BK4138","BK4097"],"gpt_icon":0},{"id":"2529014504","title":"VenoValve to be Featured During Presentation at the 47th Annual Charing Cross Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2529014504","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529014504?lang=en_us&edition=fundamental","pubTime":"2025-04-23 20:00","pubTimestamp":1745409600,"startTime":"0","endTime":"0","summary":"IRVINE, CA / ACCESS Newswire / April 23, 2025 / enVVeno Medical Corporation  , a company setting new standards of care for the treatment of deep venous disease, today announced that the VenoValve will be featured during a presentation at the Annual Charing Cross Symposium being held April 23-25, 2025 in London, England.As part of the Symposium, Dr. David Dexter, Sentara Hospital, Norfolk, Virginia and Associate Professor of Surgery, Eastern Virginia Medical School, and a Principal Investigator for the VenoValve U.S. pivotal trial, will present, \"Progress to date and future prospects for invasive correction of deep venous reflux\" onThursday, April 24, 2025 at 11:10 AM BST.The VenoValveis a potential first-in-class, surgical replacement venous valve for patients with severe deep venous CVI. The Company estimates that there are approximately 2.5 million potential new patients each year in the U.S. that could be candidates for the VenoValve. The Company has submitted a pre-market authoriza","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/venovalve-featured-during-presentation-47th-120000101.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","NVNO","BK4138","CVI"],"gpt_icon":0},{"id":"2527107662","title":"enVVeno Medical to Participate in a Live Virtual Investor Closing Bell Segment","url":"https://stock-news.laohu8.com/highlight/detail?id=2527107662","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527107662?lang=en_us&edition=fundamental","pubTime":"2025-04-16 20:30","pubTimestamp":1744806600,"startTime":"0","endTime":"0","summary":"Moderated webcast with Robert Berman, Chief Executive Officer of enVVeno Medical on Tuesday, April 22nd at 4:00 PM ET. IRVINE, CA / ACCESS Newswire / April 16, 2025 / enVVeno Medical Corporation  , a company setting new standards of care for the treatment of venous disease, today announced that Robert Berman, Chief Executive Officer of enVVeno Medical will participate in the Virtual Investor Closing Bell Series on Tuesday, April 22, 2025 at 4:00 PM ET.As part of the event, Mr. Berman will provide a corporate overview and discuss the Company's portfolio of novel implantable replacement venous valve technologies, the VenoValve and enVVe, for the treatment of severe deep venous CVI. In addition to the moderated discussion, there will be a live question and answer session. Mr. Berman will answer as many questions as possible in the time allowed.A live video webcast of the presentation will be available on the Events page of the Company's website . A webcast replay will be available two hou","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/envveno-medical-participate-live-virtual-123000168.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","BK4138","NVNO","CVI"],"gpt_icon":0},{"id":"2523947589","title":"The Impact of the VenoValve(R) on Patients with Primary and Secondary Chronic Venous Insufficiency (CVI) to be Presented at the Society for Clinical Vascular Surgery 52nd Annual Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2523947589","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523947589?lang=en_us&edition=fundamental","pubTime":"2025-03-31 21:00","pubTimestamp":1743426000,"startTime":"0","endTime":"0","summary":"IRVINE, CA / ACCESS Newswire / March 31, 2025 / enVVeno Medical Corporation  , a company setting new standards of care for the treatment of venous disease, today announced its abstract has been accepted for presentation at the Society for Clinical Vascular Surgery  52nd Annual Symposium being held March 29-April 2, 2025 in Austin, TX.As part of the SCVS Symposium, Dr. Cassius Iyad Ochoa Chaar, Associate Professor of Surgery, Yale School of Medicine, Division of Vascular and Endovascular Surgery, Principal Investigator, and lead enroller for the VenoValve U.S. pivotal trial, will present the abstract titled, \"Impact of the VenoValve on Patients with Primary and Thrombotic Deep Venous Reflux\" on Wednesday, April 2, 2025 beginning at 8:20 AM CT.The VenoValve is a potential first-in-class, surgical replacement venous valve for patients with severe deep venous CVI. The Company estimates that there are approximately 2.5 million potential new patients each year in the U.S. that could be candi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/impact-venovalve-r-patients-primary-130000336.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","BK4138","CVI","BK4022","BK4232","NVNO","R"],"gpt_icon":0},{"id":"2516300515","title":"BRIEF-enVVeno Medical Files For Mixed Shelf Of Up To $100 Million - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2516300515","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516300515?lang=en_us&edition=fundamental","pubTime":"2025-03-01 06:30","pubTimestamp":1740781833,"startTime":"0","endTime":"0","summary":"BRIEF-enVVeno Medical Files For Mixed Shelf Of Up To $100 Million - SEC FilingFeb 28  - enVVeno Medical Corp NVNO.O:ENVVENO MEDICAL CORP FILES FOR MIXED SHELF OF UP TO $100 MILLION - SEC FILINGSource text: [ID:n0001493152-25-008758]Further company coverage: NVNO.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nFWN3PJ1U4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVNO","BK4082"],"gpt_icon":0},{"id":"2516300764","title":"enVVeno Medical files $100M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2516300764","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516300764?lang=en_us&edition=fundamental","pubTime":"2025-03-01 06:30","pubTimestamp":1740781809,"startTime":"0","endTime":"0","summary":"17:29 EST enVVeno Medical (NVNO) files $100M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving br...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/envveno-medical-files-100m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/envveno-medical-files-100m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","NVNO"],"gpt_icon":0},{"id":"2514022324","title":"enVVeno Medical Corp reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2514022324","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514022324?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:52","pubTimestamp":1740750734,"startTime":"0","endTime":"0","summary":"enVVeno Medical Corp reports results for the quarter ended December 31 - Earnings SummaryenVVeno Medical Corp NVNO.OQ reported a quarterly adjusted loss of 30 cents per share for the quarter ended Dec","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nL5N3PJ1EW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVNO"],"gpt_icon":0},{"id":"2514532948","title":"enVVeno Medical FY 2024 GAAP EPS $(1.27) Beats $(1.32) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2514532948","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514532948?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:08","pubTimestamp":1740748087,"startTime":"0","endTime":"0","summary":"enVVeno Medical FY 2024 GAAP EPS $(1.27) Beats $(1.32) Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/02/44040518/envveno-medical-fy-2024-gaap-eps-1-27-beats-1-32-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"enVVeno Medical FY 2024 GAAP EPS $(1.27) Beats $(1.32) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVNO"],"gpt_icon":0},{"id":"2514324902","title":"enVVeno Medical Reports Fourth Quarter and Year-End 2024 Financial Results and Progress Towards VenoValve FDA Approval Expected in 2H25","url":"https://stock-news.laohu8.com/highlight/detail?id=2514324902","media":"ACCESS Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514324902?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:00","pubTimestamp":1740747600,"startTime":"0","endTime":"0","summary":"Cash Burn of $5.2 million in Q4 remains in line with projected $4-5 million quarterly range. Cash and investments on hand are sufficient to fund operations beyond the anticipated regulatory approval of VenoValve and the initiation of the enVVe pivotal trial. PMA application for the VenoValve submitted, with FDA decision expected in the second half of 2025. On track for enVVe IDE application submission by mid-2025, pending GLP study results. IRVINE, CA / ACCESS Newswire / February 28, 2025 / enVVeno Medical Corporation  , a company setting new standards of care for the treatment of venous disease, today provided a corporate update and reported financial results for the fourth quarter and year-end of 2024.The Company reported net losses of $21.8 million and $23.5 million for the years ended December 31, 2024 and 2023, respectively, representing a decrease in net loss of $1.7 million or 7%, resulting from a decrease in operating expenses of $1.5 million, and an increase in other income of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/envveno-medical-reports-fourth-quarter-130000940.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CVI","LU2065732104.USD","PRGS","BK4097","BK4082","IDE","NVNO","BK4138"],"gpt_icon":0},{"id":"2514057587","title":"enVVeno Medical Corp  expected to post a loss of 35 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2514057587","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514057587?lang=en_us&edition=fundamental","pubTime":"2025-02-25 05:06","pubTimestamp":1740431166,"startTime":"0","endTime":"0","summary":"enVVeno Medical Corp  expected to post a loss of35cents a share - Earnings Preview enVVeno Medical Corp NVNO.OQ NVNO.O is expected to show no change in quarterly revenue when it reports  results on Fe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL5N3PF22G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVNO"],"gpt_icon":0},{"id":"2512072481","title":"enVVeno Medical presents one-year data from VenoValve trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2512072481","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512072481?lang=en_us&edition=fundamental","pubTime":"2025-02-19 21:50","pubTimestamp":1739973022,"startTime":"0","endTime":"0","summary":"enVVeno Medical (NVNO) announced that one-year follow-up data on 75 subjects from the VenoValve U.S. pivotal trial will be presented by Dr. Cassius...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/envveno-medical-presents-one-year-data-from-venovalve-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/envveno-medical-presents-one-year-data-from-venovalve-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVNO","BK4082"],"gpt_icon":0},{"id":"2512100811","title":"One-Year Data from the VenoValve(R) U.S. Pivotal Trial Highlighting Impact on Patients' Quality of Life (QOL) to be Presented Today at the 37th Annual Meeting of the American Venous Forum","url":"https://stock-news.laohu8.com/highlight/detail?id=2512100811","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512100811?lang=en_us&edition=fundamental","pubTime":"2025-02-19 21:45","pubTimestamp":1739972700,"startTime":"0","endTime":"0","summary":"One-year follow-up data demonstrates sustained improvements across venous specific quality-of-life  indicators.PMA application for the VenoValve submitted in November 2024, with an FDA decision expected in the second half of 2025.Severe, deep venous CVI is a debilitating disease that is most often caused by blood clots  in the deep veins of the leg. When valves inside of the veins of the leg fail, blood flows in the wrong direction and pools in the lower leg, causing pressure within the veins of the leg to increase . Symptoms of severe CVI include leg swelling, pain, edema, and in the most severe cases, recurrent open sores known as venous ulcers. The disease can severely impact everyday functions such as sleeping, bathing, dressing, and walking, and is known to result in high rates of depression and anxiety. There are currently no effective treatments for severe CVI of the deep vein system caused by valvular incompetence. Estimates indicate that CVI costs the U.S. healthcare system in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/one-data-venovalve-r-u-134500871.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","CVI","BK4179","BK4117","BK4232","R","FET","BK4022","BK4138","BK4107","NVNO","AFG"],"gpt_icon":0},{"id":"2509744282","title":"Interim Two-Year Follow-Up Data from the VenoValve(R) U.S. Pivotal Trial to be Presented Today at the VESS 2025 Annual Winter Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2509744282","media":"ACCESS Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509744282?lang=en_us&edition=fundamental","pubTime":"2025-02-07 22:00","pubTimestamp":1738936800,"startTime":"0","endTime":"0","summary":"Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.78% of subjects maintained a clinically meaningful benefit of more than 3 points in rVCSS at 24 months, with an average improvement of 8.2 points among the responder cohort.Subjects continued to experience a median 75% reduction in pain at 24 months.Interim follow-up data indicate sustained improvements across all venous specific quality-of-life indicators.PMA application for the VenoValve submitted in November 2024, with an FDA decision expected in the second half of 2025.Key interim two-year follow-up data being presented at VESS includes:. Patient-reported outcomes also demonstrated sustained improvements across all venous specific QoL indicators  from 12 months to 24 months.\"The growing body of evidence from our pivotal trial further supports the contention that the VenoValve and the SAVVE procedure is a safe and effe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/interim-two-data-venovalve-r-140000277.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["R","BK4082","BK4232","BK4138","NVNO","BK4022","CVI"],"gpt_icon":0},{"id":"2504167637","title":"Companies Like enVVeno Medical (NASDAQ:NVNO) Are In A Position To Invest In Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2504167637","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504167637?lang=en_us&edition=fundamental","pubTime":"2025-01-17 22:58","pubTimestamp":1737125901,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. Having said that, unprofitable companies are risky because they could potentially burn through all their cash and become distressed.So, the natural question for enVVeno Medical  shareholders is whether they should be concerned by its rate of cash burn. In this article, we define cash burn as its annual  free cash flow, which is the amount of money a company spends each year to fund its growth. We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway.When Might enVVeno Medical Run Out Of Money?Since it has a market capitalisation of US$56m, enVVeno Medical's US$17m in cash burn equates to about 30% of its market value. That's not in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/companies-envveno-medical-nasdaq-nvno-145821147.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","USJW.SI","QID","QLD","LU2095319765.USD","BK4112","PSQ","IE00BKPKM429.USD","TQQQ","BK4585","IE00B64PRP62.GBP","NQmain","TSYW.SI","SQQQ",".IXIC","MNQmain","LU2210149790.SGD","NVIW.SI","IE00BGHQF748.EUR","LU2210150020.SGD","NDAQ","NVNO","IE00B3QW5Z07.USD","USAW.SI","BK4588"],"gpt_icon":1},{"id":"2491694066","title":"enVVeno Medical completes final wave of implants in pre-clinical GLP study","url":"https://stock-news.laohu8.com/highlight/detail?id=2491694066","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491694066?lang=en_us&edition=fundamental","pubTime":"2024-12-16 22:35","pubTimestamp":1734359708,"startTime":"0","endTime":"0","summary":"enVVeno Medical (NVNO) announced the completion of the final wave of implants for shorter-term subjects in its six-month pre-clinical GLP study for...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/envveno-medical-completes-final-wave-of-implants-in-pre-clinical-glp-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/envveno-medical-completes-final-wave-of-implants-in-pre-clinical-glp-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4144","GLP","BK4082","BK4590","NVNO"],"gpt_icon":0},{"id":"2491969198","title":"enVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for enVVe","url":"https://stock-news.laohu8.com/highlight/detail?id=2491969198","media":"ACCESSWIRE","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491969198?lang=en_us&edition=fundamental","pubTime":"2024-12-16 21:50","pubTimestamp":1734357000,"startTime":"0","endTime":"0","summary":"Successful Completion of All Planned Implants in GLP Study. Company Maintains Timeline for IDE Application Submission by Mid-2025, Pending GLP Study Results. IRVINE, CA / ACCESSWIRE / December 16, 2024 / enVVeno Medical Corporation  , a company setting new standards of care for the treatment of venous disease, today announced the successful completion of the final wave of implants for shorter-term subjects in its six-month pre-clinical GLP study for enVVe, its transcatheter-delivered replacement venous valve.The successful completion of all planned implants in the GLP study, including both long-term and short-term subjects, completes a critical phase of the study. The follow-up period, which began with the first wave of implants, is ongoing as scheduled. Pending successful completion of the GLP study, the Company anticipates submitting its IDE application to the FDA in mid-2025. The submission, if approved, would allow the Company to initiate the pivotal clinical trial for enVVe.The Co","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/PB9pfC9MTDVOfvFzLdm4CA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/bce6b2ebf1338abb393a7301ea4d0a79","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/PB9pfC9MTDVOfvFzLdm4CA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/bce6b2ebf1338abb393a7301ea4d0a79"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/envveno-medical-successfully-completes-final-135000417.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CVI","GLP","BK4144","BK4138","BK4082","NVNO","BK4590"],"gpt_icon":0},{"id":"2486382448","title":"enVVeno launches recap website highlighting VEITH Symposium participation","url":"https://stock-news.laohu8.com/highlight/detail?id=2486382448","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486382448?lang=en_us&edition=fundamental","pubTime":"2024-11-27 21:45","pubTimestamp":1732715145,"startTime":"0","endTime":"0","summary":"enVVeno Medical (NVNO) announced the launch of a recap website which highlights the Company’s participation at the recently held 51st Annual Vascul...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/envveno-launches-recap-website-highlighting-veith-symposium-participation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/envveno-launches-recap-website-highlighting-veith-symposium-participation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","NVNO"],"gpt_icon":0},{"id":"2486824818","title":"enVVeno Medical Highlights Successful 2024 VEITH Symposium with Launch of Recap Website","url":"https://stock-news.laohu8.com/highlight/detail?id=2486824818","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486824818?lang=en_us&edition=fundamental","pubTime":"2024-11-27 21:30","pubTimestamp":1732714200,"startTime":"0","endTime":"0","summary":"Interviews with participating patients from the VenoValve U.S. Pivotal Trial. Webcast replay from with the presenting Primary Investigators. Presentation with data from the VenoValve U.S. Pivotal Trial. IRVINE, CA / ACCESSWIRE / November 27, 2024 / enVVeno Medical Corporation  , a company setting new standards of care for the treatment of venous disease, today announced the launch of a recap website which highlights the Company's participation at the recently held 51st Annual Vascular and Endovascular, Techniques and Horizons  Symposium. Materials accessible on the recap website include interviews with two patients and two Principal Investigators who participated in the VenoValve U.S. Pivotal Trial as well as data presented at the symposium.Access the enVVeno Medical VEITH Symposium Recap Site at envveno.com/veith-2024. The VenoValve is a potential first-in-class, surgical replacement venous valve for patients with severe deep venous CVI. The Company estimates that there are approximat","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/NWEbupIHuZ00xaXiCGl6GA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/56089b755ed4f6f1d422e31cfc383d9c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/NWEbupIHuZ00xaXiCGl6GA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/56089b755ed4f6f1d422e31cfc383d9c"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/envveno-medical-highlights-successful-2024-133000641.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVNO","CVI","BK4138","BK4082"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":27,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVNO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-28","symbol":"NVNO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740718800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-10-31","symbol":"NVNO","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730347200000,"reportTimeType":"pre","actualEps":-0.45},{"market":"US","date":"2024-07-31","symbol":"NVNO","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722398400000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2024-05-08","symbol":"NVNO","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2024-02-29","symbol":"NVNO","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1709182800000,"reportTimeType":"post","actualEps":-0.32}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVNO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVNO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":1,"updateTime":1599192000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NVNO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NVNO","date":"2025-04-30","current":-2.386991,"percent":0.582852,"low":-9.694131,"twenty":-4.284155,"median":-2.567767,"eighty":-1.922252,"high":-0.78607,"avg":-3.107706,"sd":1.680438,"marketCap":52081765},"quantilePoints":[{"date":"2020-05-01","current":-0.945893,"twenty":-2.558617,"median":-1.69033,"eighty":-1.284417,"marketCap":7212811},{"date":"2020-05-08","current":-0.953671,"twenty":-2.552693,"median":-1.667224,"eighty":-1.27603,"marketCap":7272120},{"date":"2020-05-15","current":-0.854315,"twenty":-2.546172,"median":-1.658925,"eighty":-1.261219,"marketCap":6514488},{"date":"2020-05-22","current":-0.890695,"twenty":-2.541666,"median":-1.6488,"eighty":-1.248856,"marketCap":6791904},{"date":"2020-05-29","current":-0.817934,"twenty":-2.53097,"median":-1.637292,"eighty":-1.244688,"marketCap":6237072},{"date":"2020-06-05","current":-0.931843,"twenty":-2.515086,"median":-1.623382,"eighty":-1.225732,"marketCap":7105671},{"date":"2020-06-12","current":-1.424387,"twenty":-2.5127,"median":-1.614123,"eighty":-1.228935,"marketCap":10271865},{"date":"2020-06-19","current":-1.531988,"twenty":-2.50909,"median":-1.610953,"eighty":-1.233219,"marketCap":11047823},{"date":"2020-06-26","current":-1.278262,"twenty":-2.504779,"median":-1.6064,"eighty":-1.240323,"marketCap":9218095},{"date":"2020-07-02","current":-1.389848,"twenty":-2.496957,"median":-1.604652,"eighty":-1.244167,"marketCap":10022792},{"date":"2020-07-10","current":-1.312136,"twenty":-2.490676,"median":-1.592783,"eighty":-1.246252,"marketCap":9462378},{"date":"2020-07-17","current":-1.325088,"twenty":-2.48818,"median":-1.588361,"eighty":-1.245558,"marketCap":9555780},{"date":"2020-07-24","current":-1.698401,"twenty":-2.486088,"median":-1.589657,"eighty":-1.246252,"marketCap":12247897},{"date":"2020-07-31","current":-1.73796,"twenty":-2.47804,"median":-1.596506,"eighty":-1.246481,"marketCap":12533175},{"date":"2020-08-07","current":-1.913602,"twenty":-2.465967,"median":-1.6064,"eighty":-1.247883,"marketCap":13799805},{"date":"2020-08-14","current":-1.762648,"twenty":-2.454931,"median":-1.609109,"eighty":-1.250933,"marketCap":12148811},{"date":"2020-08-21","current":-2.558898,"twenty":-2.454931,"median":-1.61346,"eighty":-1.255627,"marketCap":17636854},{"date":"2020-08-28","current":-2.473824,"twenty":-2.465967,"median":-1.623157,"eighty":-1.257244,"marketCap":17050492},{"date":"2020-09-04","current":-2.103501,"twenty":-2.454931,"median":-1.637262,"eighty":-1.259233,"marketCap":14498092},{"date":"2020-09-11","current":-3.134956,"twenty":-2.454931,"median":-1.642378,"eighty":-1.259233,"marketCap":21607254},{"date":"2020-09-18","current":-2.449284,"twenty":-2.454931,"median":-1.651104,"eighty":-1.262543,"marketCap":16881352},{"date":"2020-09-25","current":-2.471392,"twenty":-2.468726,"median":-1.662837,"eighty":-1.262543,"marketCap":17033725},{"date":"2020-10-02","current":-2.507462,"twenty":-2.478955,"median":-1.667224,"eighty":-1.262543,"marketCap":17282334},{"date":"2020-10-09","current":-2.263115,"twenty":-2.475464,"median":-1.683886,"eighty":-1.271825,"marketCap":15598209},{"date":"2020-10-16","current":-2.244498,"twenty":-2.473824,"median":-1.690489,"eighty":-1.278262,"marketCap":15469895},{"date":"2020-10-23","current":-2.099636,"twenty":-2.471392,"median":-1.700588,"eighty":-1.278834,"marketCap":14471449},{"date":"2020-10-30","current":-1.942556,"twenty":-2.468726,"median":-1.703994,"eighty":-1.278834,"marketCap":13388797},{"date":"2020-11-06","current":-1.903577,"twenty":-2.454931,"median":-1.707875,"eighty":-1.280626,"marketCap":13120139},{"date":"2020-11-13","current":-2.453976,"twenty":-2.454931,"median":-1.722246,"eighty":-1.281583,"marketCap":16913689},{"date":"2020-11-20","current":-2.603029,"twenty":-2.454931,"median":-1.723116,"eighty":-1.284417,"marketCap":18357176},{"date":"2020-11-27","current":-2.138606,"twenty":-2.469259,"median":-1.728885,"eighty":-1.284417,"marketCap":15081953},{"date":"2020-12-04","current":-2.337978,"twenty":-2.45769,"median":-1.731697,"eighty":-1.284619,"marketCap":16487975},{"date":"2020-12-11","current":-3.655863,"twenty":-2.474152,"median":-1.735993,"eighty":-1.286517,"marketCap":25782010},{"date":"2020-12-18","current":-2.794169,"twenty":-2.487684,"median":-1.73796,"eighty":-1.286979,"marketCap":19705141},{"date":"2020-12-24","current":-2.512218,"twenty":-2.494108,"median":-1.741388,"eighty":-1.286979,"marketCap":17716753},{"date":"2020-12-31","current":-2.740313,"twenty":-2.508411,"median":-1.745415,"eighty":-1.289603,"marketCap":19325336},{"date":"2021-01-08","current":-2.949401,"twenty":-2.513939,"median":-1.746369,"eighty":-1.29407,"marketCap":20799871},{"date":"2021-01-15","current":-2.705465,"twenty":-2.522573,"median":-1.74945,"eighty":-1.29497,"marketCap":19079581},{"date":"2021-01-22","current":-2.768825,"twenty":-2.540918,"median":-1.753104,"eighty":-1.295125,"marketCap":19526409},{"date":"2021-01-29","current":-2.949401,"twenty":-2.552693,"median":-1.753138,"eighty":-1.295125,"marketCap":20799871},{"date":"2021-02-05","current":-3.09196,"twenty":-2.566584,"median":-1.762422,"eighty":-1.295125,"marketCap":21805235},{"date":"2021-02-12","current":-8.700454,"twenty":-2.568141,"median":-1.762926,"eighty":-1.29514,"marketCap":61357655},{"date":"2021-02-19","current":-9.324391,"twenty":-2.580731,"median":-1.768584,"eighty":-1.295199,"marketCap":65757805},{"date":"2021-02-26","current":-8.238278,"twenty":-2.585281,"median":-1.776307,"eighty":-1.30327,"marketCap":58098284},{"date":"2021-03-05","current":-7.394808,"twenty":-2.595068,"median":-1.785945,"eighty":-1.30327,"marketCap":52149932},{"date":"2021-03-12","current":-7.914756,"twenty":-2.597679,"median":-1.791753,"eighty":-1.309602,"marketCap":55816724},{"date":"2021-03-19","current":-8.007191,"twenty":-2.607518,"median":-1.7969,"eighty":-1.309602,"marketCap":56468599},{"date":"2021-03-26","current":-7.602787,"twenty":-2.625615,"median":-1.800703,"eighty":-1.309602,"marketCap":53616649},{"date":"2021-04-01","current":-6.338991,"twenty":-2.635757,"median":-1.813295,"eighty":-1.309804,"marketCap":57909761},{"date":"2021-04-09","current":-6.469308,"twenty":-2.647247,"median":-1.818331,"eighty":-1.31168,"marketCap":59100270},{"date":"2021-04-16","current":-5.640864,"twenty":-2.662831,"median":-1.824578,"eighty":-1.315274,"marketCap":51532034},{"date":"2021-04-23","current":-5.938731,"twenty":-2.700408,"median":-1.837027,"eighty":-1.317623,"marketCap":54253197},{"date":"2021-04-30","current":-5.777985,"twenty":-2.706459,"median":-1.844092,"eighty":-1.322876,"marketCap":52784704},{"date":"2021-05-07","current":-5.190867,"twenty":-2.724105,"median":-1.853221,"eighty":-1.324889,"marketCap":47421097},{"date":"2021-05-14","current":-4.055359,"twenty":-2.728301,"median":-1.853538,"eighty":-1.325088,"marketCap":43589949},{"date":"2021-05-21","current":-4.776135,"twenty":-2.752895,"median":-1.8574,"eighty":-1.327745,"marketCap":51337381},{"date":"2021-05-28","current":-4.681088,"twenty":-2.770726,"median":-1.876707,"eighty":-1.333511,"marketCap":50315742},{"date":"2021-06-04","current":-4.863262,"twenty":-2.794818,"median":-1.881293,"eighty":-1.334945,"marketCap":52273884},{"date":"2021-06-11","current":-4.989992,"twenty":-2.822681,"median":-1.889101,"eighty":-1.338662,"marketCap":53636070},{"date":"2021-06-18","current":-4.768215,"twenty":-2.838879,"median":-1.894579,"eighty":-1.341531,"marketCap":51252245},{"date":"2021-06-25","current":-5.3385,"twenty":-2.867479,"median":-1.905588,"eighty":-1.342896,"marketCap":57382081},{"date":"2021-07-02","current":-5.148405,"twenty":-2.879705,"median":-1.919866,"eighty":-1.343839,"marketCap":55338803},{"date":"2021-07-09","current":-5.029595,"twenty":-2.885565,"median":-1.932645,"eighty":-1.343997,"marketCap":54061753},{"date":"2021-07-16","current":-4.538517,"twenty":-2.932228,"median":-1.943429,"eighty":-1.347255,"marketCap":48783283},{"date":"2021-07-23","current":-4.887024,"twenty":-2.949401,"median":-1.959119,"eighty":-1.355274,"marketCap":52529294},{"date":"2021-07-30","current":-4.879104,"twenty":-3.002407,"median":-1.974312,"eighty":-1.359971,"marketCap":52444157},{"date":"2021-08-06","current":-5.013754,"twenty":-3.09192,"median":-1.98483,"eighty":-1.360631,"marketCap":53891480},{"date":"2021-08-13","current":-5.100895,"twenty":-3.13767,"median":-1.991502,"eighty":-1.36227,"marketCap":58659131},{"date":"2021-08-20","current":-5.545095,"twenty":-3.320113,"median":-2.016203,"eighty":-1.36395,"marketCap":63767328},{"date":"2021-08-27","current":-5.670952,"twenty":-3.415497,"median":-2.034185,"eighty":-1.366378,"marketCap":65214650},{"date":"2021-09-03","current":-5.989295,"twenty":-3.562362,"median":-2.038892,"eighty":-1.369078,"marketCap":68875525},{"date":"2021-09-10","current":-6.54003,"twenty":-3.68308,"median":-2.049685,"eighty":-1.370106,"marketCap":75208852},{"date":"2021-09-17","current":-7.121534,"twenty":-4.023309,"median":-2.069784,"eighty":-1.370794,"marketCap":81896013},{"date":"2021-09-24","current":-7.514237,"twenty":-4.145653,"median":-2.086376,"eighty":-1.372993,"marketCap":86412018},{"date":"2021-10-01","current":-7.733245,"twenty":-4.274628,"median":-2.097018,"eighty":-1.376267,"marketCap":88930560},{"date":"2021-10-08","current":-7.061118,"twenty":-4.405162,"median":-2.116122,"eighty":-1.382634,"marketCap":81201243},{"date":"2021-10-15","current":-7.551998,"twenty":-4.472961,"median":-2.141523,"eighty":-1.383425,"marketCap":86846250},{"date":"2021-10-22","current":-7.476478,"twenty":-4.536065,"median":-2.15078,"eighty":-1.384592,"marketCap":85977787},{"date":"2021-10-29","current":-6.660862,"twenty":-4.582884,"median":-2.160629,"eighty":-1.384725,"marketCap":76598392},{"date":"2021-11-05","current":-7.105501,"twenty":-4.679504,"median":-2.180503,"eighty":-1.384725,"marketCap":81711636},{"date":"2021-11-12","current":-6.23857,"twenty":-4.70485,"median":-2.191439,"eighty":-1.384811,"marketCap":74326343},{"date":"2021-11-19","current":-5.880945,"twenty":-4.75871,"median":-2.197391,"eighty":-1.385156,"marketCap":70065597},{"date":"2021-11-26","current":-5.722001,"twenty":-4.768215,"median":-2.20196,"eighty":-1.385156,"marketCap":68171932},{"date":"2021-12-03","current":-4.95112,"twenty":-4.801663,"median":-2.222231,"eighty":-1.385156,"marketCap":58987658},{"date":"2021-12-10","current":-5.761737,"twenty":-4.850968,"median":-2.226818,"eighty":-1.385156,"marketCap":68645349},{"date":"2021-12-17","current":-5.332587,"twenty":-4.926627,"median":-2.239692,"eighty":-1.385156,"marketCap":63532454},{"date":"2021-12-23","current":-5.396164,"twenty":-4.942469,"median":-2.249443,"eighty":-1.38891,"marketCap":64289919},{"date":"2021-12-31","current":-5.23722,"twenty":-4.96623,"median":-2.261724,"eighty":-1.391177,"marketCap":62396255},{"date":"2022-01-07","current":-5.197484,"twenty":-4.994744,"median":-2.265886,"eighty":-1.3939,"marketCap":61922838},{"date":"2022-01-14","current":-5.086223,"twenty":-5.014895,"median":-2.270268,"eighty":-1.397098,"marketCap":60597273},{"date":"2022-01-21","current":-4.609389,"twenty":-5.016036,"median":-2.274206,"eighty":-1.397825,"marketCap":54916279},{"date":"2022-01-28","current":-4.219975,"twenty":-5.013754,"median":-2.279766,"eighty":-1.39976,"marketCap":50276800},{"date":"2022-02-04","current":-4.231896,"twenty":-5.013754,"median":-2.309199,"eighty":-1.401016,"marketCap":50418825},{"date":"2022-02-11","current":-4.212028,"twenty":-5.013754,"median":-2.323329,"eighty":-1.401016,"marketCap":50182117},{"date":"2022-02-18","current":-3.886192,"twenty":-5.009552,"median":-2.329175,"eighty":-1.402086,"marketCap":46300104},{"date":"2022-02-25","current":-4.003255,"twenty":-5.000047,"median":-2.33833,"eighty":-1.403448,"marketCap":47694788},{"date":"2022-03-04","current":-3.902086,"twenty":-4.988332,"median":-2.355,"eighty":-1.404825,"marketCap":46489470},{"date":"2022-03-11","current":-3.941823,"twenty":-4.98275,"median":-2.36803,"eighty":-1.4055,"marketCap":46962887},{"date":"2022-03-18","current":-4.14845,"twenty":-4.973359,"median":-2.372267,"eighty":-1.405823,"marketCap":49424651},{"date":"2022-03-25","current":-3.814667,"twenty":-4.96623,"median":-2.378893,"eighty":-1.407831,"marketCap":45447955},{"date":"2022-04-01","current":-3.68412,"twenty":-4.960186,"median":-2.381212,"eighty":-1.410697,"marketCap":60891135},{"date":"2022-04-08","current":-3.27732,"twenty":-4.950828,"median":-2.391045,"eighty":-1.413662,"marketCap":54167542},{"date":"2022-04-14","current":-3.101995,"twenty":-4.948946,"median":-2.407674,"eighty":-1.417947,"marketCap":51269767},{"date":"2022-04-22","current":-2.778846,"twenty":-4.943032,"median":-2.417764,"eighty":-1.420539,"marketCap":45928772},{"date":"2022-04-29","current":-2.232891,"twenty":-4.942469,"median":-2.420346,"eighty":-1.420974,"marketCap":42614325},{"date":"2022-05-06","current":-2.163423,"twenty":-4.940885,"median":-2.415755,"eighty":-1.422336,"marketCap":41288546},{"date":"2022-05-13","current":-2.034412,"twenty":-4.933624,"median":-2.394345,"eighty":-1.422731,"marketCap":38826385},{"date":"2022-05-20","current":-2.064184,"twenty":-4.929266,"median":-2.385879,"eighty":-1.423224,"marketCap":39394576},{"date":"2022-05-27","current":-2.061703,"twenty":-4.918706,"median":-2.380052,"eighty":-1.425118,"marketCap":39347226},{"date":"2022-06-03","current":-2.128689,"twenty":-4.887024,"median":-2.375052,"eighty":-1.42804,"marketCap":40625656},{"date":"2022-06-10","current":-1.875628,"twenty":-4.879104,"median":-2.369551,"eighty":-1.429315,"marketCap":35796033},{"date":"2022-06-17","current":-1.786313,"twenty":-4.863262,"median":-2.363261,"eighty":-1.430237,"marketCap":34091460},{"date":"2022-06-24","current":-1.885552,"twenty":-4.853427,"median":-2.352388,"eighty":-1.434168,"marketCap":35985430},{"date":"2022-07-01","current":-1.920286,"twenty":-4.829121,"median":-2.338154,"eighty":-1.43545,"marketCap":36648319},{"date":"2022-07-08","current":-2.471066,"twenty":-4.823659,"median":-2.333577,"eighty":-1.443912,"marketCap":47159853},{"date":"2022-07-15","current":-2.629849,"twenty":-4.814154,"median":-2.344314,"eighty":-1.449503,"marketCap":50190205},{"date":"2022-07-22","current":-2.525648,"twenty":-4.804125,"median":-2.360437,"eighty":-1.44959,"marketCap":48201536},{"date":"2022-07-29","current":-2.624887,"twenty":-4.800603,"median":-2.36803,"eighty":-1.449648,"marketCap":50095506},{"date":"2022-08-05","current":-2.370568,"twenty":-4.799897,"median":-2.369299,"eighty":-1.449835,"marketCap":56345607},{"date":"2022-08-12","current":-2.374552,"twenty":-4.78564,"median":-2.370568,"eighty":-1.450158,"marketCap":56440306},{"date":"2022-08-19","current":-2.502045,"twenty":-4.771383,"median":-2.37082,"eighty":-1.454254,"marketCap":59470658},{"date":"2022-08-26","current":-2.784919,"twenty":-4.767933,"median":-2.374552,"eighty":-1.457579,"marketCap":66194251},{"date":"2022-09-02","current":-2.873009,"twenty":-4.764956,"median":-2.379473,"eighty":-1.459565,"marketCap":68288035},{"date":"2022-09-09","current":-2.924364,"twenty":-4.761975,"median":-2.381212,"eighty":-1.460636,"marketCap":69508699},{"date":"2022-09-16","current":-3.027952,"twenty":-4.757126,"median":-2.389647,"eighty":-1.460811,"marketCap":71970860},{"date":"2022-09-23","current":-2.454235,"twenty":-4.752374,"median":-2.392695,"eighty":-1.463049,"marketCap":58334276},{"date":"2022-09-30","current":-2.502045,"twenty":-4.733364,"median":-2.407674,"eighty":-1.466179,"marketCap":59470658},{"date":"2022-10-07","current":-2.482124,"twenty":-4.70485,"median":-2.412684,"eighty":-1.466179,"marketCap":58997165},{"date":"2022-10-14","current":-2.286901,"twenty":-4.70485,"median":-2.407674,"eighty":-1.467114,"marketCap":54356939},{"date":"2022-10-21","current":-2.442283,"twenty":-4.70485,"median":-2.403066,"eighty":-1.472567,"marketCap":58050180},{"date":"2022-10-28","current":-2.154528,"twenty":-4.701634,"median":-2.407674,"eighty":-1.480173,"marketCap":59199575},{"date":"2022-11-04","current":-2.05111,"twenty":-4.695499,"median":-2.392695,"eighty":-1.48384,"marketCap":56357995},{"date":"2022-11-11","current":-2.099372,"twenty":-4.688555,"median":-2.390489,"eighty":-1.485895,"marketCap":57684065},{"date":"2022-11-18","current":-2.054558,"twenty":-4.67792,"median":-2.382315,"eighty":-1.485895,"marketCap":56452714},{"date":"2022-11-25","current":-2.030427,"twenty":-4.671538,"median":-2.380183,"eighty":-1.486944,"marketCap":55789679},{"date":"2022-12-02","current":-2.043837,"twenty":-4.656947,"median":-2.375052,"eighty":-1.491803,"marketCap":56158137},{"date":"2022-12-09","current":-1.98906,"twenty":-4.623269,"median":-2.374007,"eighty":-1.495321,"marketCap":54653047},{"date":"2022-12-16","current":-1.802909,"twenty":-4.616056,"median":-2.370568,"eighty":-1.498767,"marketCap":49538204},{"date":"2022-12-23","current":-1.565049,"twenty":-4.604719,"median":-2.367307,"eighty":-1.498915,"marketCap":43002571},{"date":"2022-12-30","current":-1.758095,"twenty":-4.586041,"median":-2.360437,"eighty":-1.499411,"marketCap":48306853},{"date":"2023-01-06","current":-1.771884,"twenty":-4.573415,"median":-2.349585,"eighty":-1.504716,"marketCap":48685730},{"date":"2023-01-13","current":-1.623652,"twenty":-4.570211,"median":-2.344314,"eighty":-1.506733,"marketCap":44612799},{"date":"2023-01-20","current":-1.682255,"twenty":-4.560694,"median":-2.337978,"eighty":-1.507343,"marketCap":46223028},{"date":"2023-01-27","current":-1.816698,"twenty":-4.544853,"median":-2.328143,"eighty":-1.507634,"marketCap":49917081},{"date":"2023-02-03","current":-2.147633,"twenty":-4.531162,"median":-2.322758,"eighty":-1.508859,"marketCap":59010136},{"date":"2023-02-10","current":-2.123503,"twenty":-4.500346,"median":-2.319122,"eighty":-1.510671,"marketCap":58347101},{"date":"2023-02-17","current":-1.944246,"twenty":-4.479465,"median":-2.310806,"eighty":-1.513565,"marketCap":53421696},{"date":"2023-02-24","current":-1.906326,"twenty":-4.476297,"median":-2.298233,"eighty":-1.515052,"marketCap":52379783},{"date":"2023-03-03","current":-2.192417,"twenty":-4.47077,"median":-2.281341,"eighty":-1.515052,"marketCap":54084731},{"date":"2023-03-10","current":-1.928098,"twenty":-4.46034,"median":-2.277549,"eighty":-1.517825,"marketCap":47564253},{"date":"2023-03-17","current":-1.946682,"twenty":-4.453289,"median":-2.273371,"eighty":-1.522043,"marketCap":48022695},{"date":"2023-03-24","current":-1.843012,"twenty":-4.435549,"median":-2.268933,"eighty":-1.522557,"marketCap":45465273},{"date":"2023-03-31","current":-1.796937,"twenty":-4.411356,"median":-2.263678,"eighty":-1.523197,"marketCap":44328641},{"date":"2023-04-06","current":-1.992757,"twenty":-4.410709,"median":-2.260565,"eighty":-1.524092,"marketCap":49159327},{"date":"2023-04-14","current":-1.808456,"twenty":-4.404351,"median":-2.254389,"eighty":-1.528405,"marketCap":44612799},{"date":"2023-04-21","current":-1.693268,"twenty":-4.378869,"median":-2.242017,"eighty":-1.531472,"marketCap":41771220},{"date":"2023-04-28","current":-1.612636,"twenty":-4.377125,"median":-2.239692,"eighty":-1.524092,"marketCap":39782114},{"date":"2023-05-05","current":-1.369383,"twenty":-4.369368,"median":-2.23041,"eighty":-1.519249,"marketCap":35235587},{"date":"2023-05-12","current":-1.744859,"twenty":-4.366157,"median":-2.227374,"eighty":-1.520617,"marketCap":44896957},{"date":"2023-05-19","current":-1.446687,"twenty":-4.360305,"median":-2.22549,"eighty":-1.515052,"marketCap":37224692},{"date":"2023-05-26","current":-1.13379,"twenty":-4.336764,"median":-2.210173,"eighty":-1.508451,"marketCap":29173550},{"date":"2023-06-02","current":-1.093298,"twenty":-4.294679,"median":-2.20017,"eighty":-1.504716,"marketCap":28131638},{"date":"2023-06-09","current":-1.019675,"twenty":-4.280923,"median":-2.192417,"eighty":-1.494109,"marketCap":26237251},{"date":"2023-06-16","current":-1.06753,"twenty":-4.224743,"median":-2.173488,"eighty":-1.486665,"marketCap":27468602},{"date":"2023-06-22","current":-1.00495,"twenty":-4.188187,"median":-2.168317,"eighty":-1.48384,"marketCap":25858374},{"date":"2023-06-30","current":-1.056486,"twenty":-4.164345,"median":-2.157813,"eighty":-1.466179,"marketCap":27184444},{"date":"2023-07-07","current":-1.255267,"twenty":-4.172292,"median":-2.147633,"eighty":-1.464266,"marketCap":32299288},{"date":"2023-07-14","current":-1.203732,"twenty":-4.180239,"median":-2.138606,"eighty":-1.46066,"marketCap":30973217},{"date":"2023-07-19","current":-1.339934,"twenty":-4.180239,"median":-2.128689,"eighty":-1.457419,"marketCap":34477832},{"date":"2023-07-27","current":-1.840568,"twenty":-4.204081,"median":-2.121963,"eighty":-1.456896,"marketCap":47359660},{"date":"2023-08-04","current":-1.981574,"twenty":-4.20726,"median":-2.111001,"eighty":-1.454254,"marketCap":49822720},{"date":"2023-08-11","current":-1.908113,"twenty":-4.208849,"median":-2.099636,"eighty":-1.452933,"marketCap":47975680},{"date":"2023-08-18","current":-1.800746,"twenty":-4.208849,"median":-2.099636,"eighty":-1.452933,"marketCap":45276160},{"date":"2023-08-25","current":-1.653823,"twenty":-4.208849,"median":-2.099636,"eighty":-1.452933,"marketCap":41582080},{"date":"2023-09-01","current":-1.864789,"twenty":-4.210439,"median":-2.101568,"eighty":-1.451612,"marketCap":46886400},{"date":"2023-09-08","current":-1.958971,"twenty":-4.210439,"median":-2.101568,"eighty":-1.451612,"marketCap":49254400},{"date":"2023-09-15","current":-2.105893,"twenty":-4.210439,"median":-2.103566,"eighty":-1.451612,"marketCap":52948480},{"date":"2023-09-22","current":-2.04185,"twenty":-4.210439,"median":-2.111001,"eighty":-1.451612,"marketCap":51338240},{"date":"2023-09-29","current":-1.876091,"twenty":-4.212028,"median":-2.108841,"eighty":-1.450291,"marketCap":47170560},{"date":"2023-10-06","current":-2.128497,"twenty":-4.212028,"median":-2.105893,"eighty":-1.450291,"marketCap":53516800},{"date":"2023-10-13","current":-1.883626,"twenty":-4.212028,"median":-2.105893,"eighty":-1.450291,"marketCap":47360000},{"date":"2023-10-20","current":-2.064454,"twenty":-4.213617,"median":-2.105893,"eighty":-1.450225,"marketCap":51906560},{"date":"2023-10-27","current":-1.940134,"twenty":-4.218386,"median":-2.108841,"eighty":-1.450025,"marketCap":48780800},{"date":"2023-11-03","current":-2.453225,"twenty":-4.218386,"median":-2.120424,"eighty":-1.45782,"marketCap":58992697},{"date":"2023-11-10","current":-2.442149,"twenty":-4.218386,"median":-2.128497,"eighty":-1.45782,"marketCap":58726364},{"date":"2023-11-17","current":-2.4643,"twenty":-4.219975,"median":-2.137319,"eighty":-1.457767,"marketCap":59259030},{"date":"2023-11-24","current":-2.104346,"twenty":-4.219975,"median":-2.143571,"eighty":-1.457767,"marketCap":50603216},{"date":"2023-12-01","current":-1.916063,"twenty":-4.219975,"median":-2.143571,"eighty":-1.457767,"marketCap":46075560},{"date":"2023-12-08","current":-2.068351,"twenty":-4.218386,"median":-2.143566,"eighty":-1.458331,"marketCap":49737635},{"date":"2023-12-14","current":-2.12096,"twenty":-4.218386,"median":-2.143566,"eighty":-1.458331,"marketCap":51002715},{"date":"2023-12-22","current":-2.724575,"twenty":-4.219975,"median":-2.149207,"eighty":-1.468517,"marketCap":65517849},{"date":"2023-12-29","current":-2.929472,"twenty":-4.219975,"median":-2.158461,"eighty":-1.485895,"marketCap":70445004},{"date":"2024-01-05","current":-2.608282,"twenty":-4.219975,"median":-2.162555,"eighty":-1.490591,"marketCap":62721355},{"date":"2024-01-12","current":-2.281554,"twenty":-4.219975,"median":-2.170014,"eighty":-1.499163,"marketCap":54864540},{"date":"2024-01-19","current":-2.181875,"twenty":-4.219975,"median":-2.181875,"eighty":-1.511979,"marketCap":52467545},{"date":"2024-01-26","current":-2.39231,"twenty":-4.219975,"median":-2.192806,"eighty":-1.522072,"marketCap":57527867},{"date":"2024-02-02","current":-2.381234,"twenty":-4.219975,"median":-2.201065,"eighty":-1.534402,"marketCap":57261534},{"date":"2024-02-09","current":-2.386772,"twenty":-4.219975,"median":-2.222231,"eighty":-1.557481,"marketCap":57394701},{"date":"2024-02-16","current":-2.713499,"twenty":-4.219975,"median":-2.231715,"eighty":-1.56562,"marketCap":65251516},{"date":"2024-02-23","current":-3.067915,"twenty":-4.219975,"median":-2.239658,"eighty":-1.57397,"marketCap":73774163},{"date":"2024-03-01","current":-3.45002,"twenty":-4.219975,"median":-2.254389,"eighty":-1.585756,"marketCap":82962642},{"date":"2024-03-08","current":-3.3184,"twenty":-4.219975,"median":-2.263115,"eighty":-1.612636,"marketCap":78035486},{"date":"2024-03-15","current":-3.210807,"twenty":-4.219975,"median":-2.270479,"eighty":-1.62356,"marketCap":75505326},{"date":"2024-03-22","current":-3.38069,"twenty":-4.219975,"median":-2.270479,"eighty":-1.62356,"marketCap":79500316},{"date":"2024-03-28","current":-2.989957,"twenty":-4.219975,"median":-2.274206,"eighty":-1.62356,"marketCap":70311838},{"date":"2024-04-05","current":-2.916341,"twenty":-4.219975,"median":-2.281554,"eighty":-1.623514,"marketCap":68580675},{"date":"2024-04-12","current":-2.871039,"twenty":-4.219975,"median":-2.310806,"eighty":-1.623514,"marketCap":67515344},{"date":"2024-04-19","current":-2.706817,"twenty":-4.219975,"median":-2.310806,"eighty":-1.623514,"marketCap":63653520},{"date":"2024-04-26","current":-2.961643,"twenty":-4.219975,"median":-2.318115,"eighty":-1.62356,"marketCap":69646006},{"date":"2024-05-03","current":-2.865376,"twenty":-4.219975,"median":-2.318115,"eighty":-1.62356,"marketCap":67382178},{"date":"2024-05-10","current":-2.99257,"twenty":-4.219975,"median":-2.318115,"eighty":-1.62356,"marketCap":66183680},{"date":"2024-05-17","current":-2.983519,"twenty":-4.219975,"median":-2.318115,"eighty":-1.62356,"marketCap":65983500},{"date":"2024-05-24","current":-2.971464,"twenty":-4.219975,"median":-2.318115,"eighty":-1.62356,"marketCap":65716900},{"date":"2024-05-31","current":-2.905164,"twenty":-4.219975,"median":-2.318115,"eighty":-1.62356,"marketCap":64250600},{"date":"2024-06-07","current":-2.947355,"twenty":-4.219975,"median":-2.318115,"eighty":-1.62356,"marketCap":65183700},{"date":"2024-06-14","current":-2.844891,"twenty":-4.219975,"median":-2.320319,"eighty":-1.623634,"marketCap":62917600},{"date":"2024-06-21","current":-2.814754,"twenty":-4.219975,"median":-2.326529,"eighty":-1.649055,"marketCap":62251100},{"date":"2024-06-28","current":-3.11612,"twenty":-4.222359,"median":-2.334352,"eighty":-1.664286,"marketCap":68916100},{"date":"2024-07-05","current":-3.043792,"twenty":-4.222359,"median":-2.346723,"eighty":-1.671304,"marketCap":67316500},{"date":"2024-07-12","current":-3.58625,"twenty":-4.222359,"median":-2.362098,"eighty":-1.682022,"marketCap":79313500},{"date":"2024-07-15","current":-3.610359,"twenty":-4.222359,"median":-2.368372,"eighty":-1.682226,"marketCap":79846700},{"date":"2024-08-02","current":-3.449311,"twenty":-4.277195,"median":-2.381234,"eighty":-1.706899,"marketCap":71048900},{"date":"2024-08-09","current":-3.300466,"twenty":-4.277195,"median":-2.38211,"eighty":-1.709671,"marketCap":67983000},{"date":"2024-08-16","current":-3.520497,"twenty":-4.277195,"median":-2.38211,"eighty":-1.709671,"marketCap":72515200},{"date":"2024-08-23","current":-3.48814,"twenty":-4.277195,"median":-2.38211,"eighty":-1.709671,"marketCap":71848700},{"date":"2024-08-30","current":-3.429896,"twenty":-4.277195,"median":-2.38211,"eighty":-1.709671,"marketCap":70649000},{"date":"2024-09-06","current":-3.339295,"twenty":-4.277195,"median":-2.38211,"eighty":-1.709671,"marketCap":68782800},{"date":"2024-09-13","current":-3.397539,"twenty":-4.277195,"median":-2.38211,"eighty":-1.709671,"marketCap":69982500},{"date":"2024-09-20","current":-3.306938,"twenty":-4.277195,"median":-2.38211,"eighty":-1.709671,"marketCap":68116300},{"date":"2024-09-27","current":-2.912176,"twenty":-4.277195,"median":-2.386772,"eighty":-1.709671,"marketCap":59985000},{"date":"2024-10-04","current":-2.707268,"twenty":-4.277195,"median":-2.39231,"eighty":-1.709671,"marketCap":55764314},{"date":"2024-10-11","current":-2.656188,"twenty":-4.277195,"median":-2.414959,"eighty":-1.709671,"marketCap":54712157},{"date":"2024-10-18","current":-2.792403,"twenty":-4.277195,"median":-2.426346,"eighty":-1.720858,"marketCap":57517909},{"date":"2024-10-25","current":-2.928617,"twenty":-4.277195,"median":-2.436612,"eighty":-1.720858,"marketCap":60323661},{"date":"2024-10-31","current":-2.817943,"twenty":-4.277195,"median":-2.443466,"eighty":-1.720858,"marketCap":58043987},{"date":"2024-11-08","current":-2.898026,"twenty":-4.283553,"median":-2.451255,"eighty":-1.723987,"marketCap":61551177},{"date":"2024-11-15","current":-2.815461,"twenty":-4.283553,"median":-2.466083,"eighty":-1.730048,"marketCap":59797582},{"date":"2024-11-22","current":-2.72464,"twenty":-4.283553,"median":-2.471229,"eighty":-1.741388,"marketCap":57868628},{"date":"2024-11-29","current":-2.567767,"twenty":-4.283553,"median":-2.475746,"eighty":-1.748005,"marketCap":54536798},{"date":"2024-12-06","current":-2.501715,"twenty":-4.283553,"median":-2.481557,"eighty":-1.756314,"marketCap":53133922},{"date":"2024-12-13","current":-2.336585,"twenty":-4.283553,"median":-2.487791,"eighty":-1.762926,"marketCap":49626732},{"date":"2024-12-20","current":-2.088891,"twenty":-4.283553,"median":-2.487791,"eighty":-1.786879,"marketCap":44365948},{"date":"2024-12-27","current":-2.526484,"twenty":-4.283553,"median":-2.493458,"eighty":-1.790881,"marketCap":53660000},{"date":"2025-01-03","current":-2.534741,"twenty":-4.283553,"median":-2.50188,"eighty":-1.796937,"marketCap":53835360},{"date":"2025-01-10","current":-2.774179,"twenty":-4.283854,"median":-2.506029,"eighty":-1.802476,"marketCap":58920785},{"date":"2025-01-17","current":-2.625562,"twenty":-4.283854,"median":-2.50905,"eighty":-1.815567,"marketCap":55764314},{"date":"2025-01-24","current":-2.881513,"twenty":-4.283854,"median":-2.518554,"eighty":-1.827654,"marketCap":61200458},{"date":"2025-01-31","current":-2.708127,"twenty":-4.283854,"median":-2.526484,"eighty":-1.836295,"marketCap":57517909},{"date":"2025-02-07","current":-2.567767,"twenty":-4.283854,"median":-2.54073,"eighty":-1.843876,"marketCap":54536798},{"date":"2025-02-14","current":-2.881513,"twenty":-4.283854,"median":-2.542997,"eighty":-1.853488,"marketCap":61200458},{"date":"2025-02-21","current":-3.153977,"twenty":-4.283854,"median":-2.55542,"eighty":-1.869491,"marketCap":66987321},{"date":"2025-02-28","current":-2.914539,"twenty":-4.283854,"median":-2.567767,"eighty":-1.880253,"marketCap":61901896},{"date":"2025-03-07","current":-2.41111,"twenty":-4.284155,"median":-2.567767,"eighty":-1.883626,"marketCap":52608000},{"date":"2025-03-14","current":-2.242332,"twenty":-4.284155,"median":-2.567767,"eighty":-1.888917,"marketCap":48925440},{"date":"2025-03-21","current":-2.330739,"twenty":-4.284155,"median":-2.567767,"eighty":-1.899668,"marketCap":50854400},{"date":"2025-03-28","current":-2.27448,"twenty":-4.284155,"median":-2.567767,"eighty":-1.903314,"marketCap":49626880},{"date":"2025-04-04","current":-1.993184,"twenty":-4.284155,"median":-2.567767,"eighty":-1.912306,"marketCap":43489280},{"date":"2025-04-11","current":-1.703851,"twenty":-4.283854,"median":-2.567767,"eighty":-1.909912,"marketCap":37176320},{"date":"2025-04-17","current":-1.912814,"twenty":-4.283854,"median":-2.567767,"eighty":-1.912324,"marketCap":41735680},{"date":"2025-04-25","current":-2.194103,"twenty":-4.284155,"median":-2.567767,"eighty":-1.918932,"marketCap":47873138},{"date":"2025-04-30","current":-2.386991,"twenty":-4.284155,"median":-2.567767,"eighty":-1.922252,"marketCap":52081765}],"updateTime":1746092256110}}}